PMID- 19772927 OWN - NLM STAT- MEDLINE DCOM- 20100212 LR - 20201209 IS - 1095-8274 (Electronic) IS - 1075-9964 (Linking) VI - 15 IP - 6 DP - 2009 Dec TI - Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area. PG - 266-9 LID - 10.1016/j.anaerobe.2009.09.008 [doi] AB - Enzyme immunoassays for TcdA and/or TcdB are widely used for diagnosis of C. difficile infection. This study compared the performance of the new VIDAS C. difficile Toxin A & B assay (CDAB) with that of the existing VIDAS C. difficile Toxin A II assay (CDA) in a tcdA(-)tcdB(+) prevalent area. A total of 555 fecal samples were cultured and tested using CDAB and CDA. C. difficile was isolated in 150 samples and the concordance rate was 81.8% (454/555) between CDAB and CDA. PCR assays for tcdA and/or tcdB were used as a confirmatory test on C. difficile strains recovered from culture positive cases (n=150) and on fecal specimens in culture negative/CDAB positive or equivocal cases (n=27). The number of tcdA(+)tcdB(+), tcdA(-)tcdB(+), and tcdA(-)tcdB(-) strains on culture positive isolates (n=150) were 75 (50.0%), 41 (27.3%), and 34 (22.7%), respectively. PCR assays for tcdB gene alone in stool specimens (n=27) showed positivity in five cases. The sensitivity of VIDAS CDAB was higher than that of VIDAS CDA (65.3% vs. 29.8%), by more than 2-fold. The specificity of CDAB was almost the same as CDA (93.8% vs. 94.5%). Toxigenic culture of C. difficile isolates in culture positive/VIDAS CDAB negative cases (n=62) additionally detected 22 VIDAS CDAB positive and 9 VIDAS CDAB equivocal cases. The VIDAS CDAB assay detects more tcdA(+)tcdB(+) strains (60% vs. 45.3%) and tcdA(-)tcdB(+) strains (70.7% vs. 0%) compared with VIDAS CDA. FAU - Shin, Bo-Moon AU - Shin BM AD - Department of Laboratory Medicine, Sanggye Paik Hospital, Inje University, Seoul, 139 707, Korea. bmshin@unitel.co.kr FAU - Lee, Eun-Joo AU - Lee EJ FAU - Kuak, Eun-Young AU - Kuak EY FAU - Yoo, Soo Jin AU - Yoo SJ LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article DEP - 20090920 PL - England TA - Anaerobe JT - Anaerobe JID - 9505216 RN - 0 (Bacterial Proteins) RN - 0 (Bacterial Toxins) RN - 0 (Culture Media) RN - 0 (DNA, Bacterial) RN - 0 (Enterotoxins) RN - 0 (Reagent Kits, Diagnostic) RN - 0 (tcdA protein, Clostridium difficile) RN - 0 (toxB protein, Clostridium difficile) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Bacterial Proteins/*analysis/genetics MH - Bacterial Toxins/*analysis/genetics MH - Child MH - *Clostridioides difficile/genetics/isolation & purification/metabolism MH - Culture Media MH - DNA, Bacterial/analysis MH - Enterocolitis, Pseudomembranous/*diagnosis/epidemiology/microbiology MH - Enterotoxins/*analysis/genetics MH - Feces/chemistry/microbiology MH - Female MH - Humans MH - Immunoenzyme Techniques/*methods MH - Korea/epidemiology MH - Male MH - Middle Aged MH - Polymerase Chain Reaction MH - Prevalence MH - Reagent Kits, Diagnostic MH - Sensitivity and Specificity MH - Young Adult EDAT- 2009/09/24 06:00 MHDA- 2010/02/13 06:00 CRDT- 2009/09/24 06:00 PHST- 2009/04/14 00:00 [received] PHST- 2009/08/28 00:00 [revised] PHST- 2009/09/11 00:00 [accepted] PHST- 2009/09/24 06:00 [entrez] PHST- 2009/09/24 06:00 [pubmed] PHST- 2010/02/13 06:00 [medline] AID - S1075-9964(09)00131-0 [pii] AID - 10.1016/j.anaerobe.2009.09.008 [doi] PST - ppublish SO - Anaerobe. 2009 Dec;15(6):266-9. doi: 10.1016/j.anaerobe.2009.09.008. Epub 2009 Sep 20.